Abstracts

413 – bNAb Sensitivity Continuously Enhances Immune Response in an HIV Dynamics Model

Background Analytical treatment interruption (ATI) is critical to investigate immunologic post-treatment control (PTC) in people living with HIV (PWH). In the eCLEAR study, newly diagnosed PWH were randomized to start ART only, ART+the broadly neutralizing antibody (bnAb) 3BNC117, ART+romidepsin (a latency reversal drug), or ART+3BNC117+romidepsin. One year later, 20 PWH underwent ATI. Individuals whose viruses…

445 – Predictors of Cognitive Intraindividual Variability in Women With and Without HIV in the MWCCS

Background Mean-based approaches of measuring cognition ignore variability in cognitive performance; yet higher levels of cognitive intra-individual variability (IIV) are associated with underlying neuropathology. Prior literature demonstrates the predictive value that cognitive IIV has on several important outcomes including everyday functioning tasks, cognitive decline, and even mortality, but to our knowledge, there have not been…

507 – Association Between Silent Transfers and Virologic Outcomes Among Female Sex Workers on ART in Kenya

Background Tracing studies in sub-Saharan Africa estimate that up to 50% of individuals classified as lost to follow-up have actually re-engaged in HIV care at different facilities without formal documentation. These largely untracked “silent transfers” may obscure programmatic estimates of retention, disrupt continuity of care, and compromise treatment outcomes. While Female Sex Workers(FSW) in Kenya…

792 – LA CAB/RPV in Pregnancy: Bimonthly Dosing in the Setting of Predicted Reduced RPV Exposure

Background Long-acting cabotegravir and rilpivirine (LA CAB/RPV) provides an alternative to daily oral antiretroviral therapy and has shown high effectiveness and acceptability in non-pregnant populations. During pregnancy, physiologic changes can reduce antiretroviral (ARV) drug concentrations. Pharmacokinetic (PK) modeling indicates that adequate CAB exposure is maintained with monthly dosing; however, there is concern that RPV concentrations…

1013 – Trajectory in Syphilis Infection and Reinfection Among People Living With HIV, 2021-2024

Background Syphilis remains a significant global public health challenge, especially among people living with HIV (PLWH), who face a high risk of acquisition and reinfection. While worldwide and regional data show increasing trends, there is limited longitudinal data from Latin American HIV cohorts. This study describes the trajectory of syphilis infection and reinfection by year…

1034 – Real-Life Evaluation of a Molecular Syndromic Panel for Infectious Genital Ulcer Diagnosis

Background Genital ulcer disease (GUD) is commonly caused by sexually transmitted infections (STIs) and typically occurs in genital, anorectal, or perineal areas, with herpes simplex virus (HSV) and Treponema pallidum (TP) being the most frequent pathogens, while Haemophilus ducreyi (HD) and Chlamydia trachomatis serovar L (CT-LGV) occur less often. Recently, mpox has emerged as an…

591 – Regional Differences in HBV Vaccine History and Response in ACTG A5379: Africa, Asia, Brazil, and US

Background As use of long-acting (LA) ART without HBV activity increases, optimizing HBV prevention in PWH is increasingly important. HepB-CpG, an adjuvanted HBV vaccine, has superior immunogenicity to HepB-alum. Understanding regional variation in revaccination outcomes may inform tailored vaccine strategies. Methods BEeHIVe (ACTG5379, PMID 39616603) enrolled PWH from 41 sites in Africa, Asia, Brazil, and…

331 – Subset of People With HIV (PWH) Continue to Have Decay in Intact Proviral DNA During Long-Term ART

Background Factors that affect intact proviral DNA (IPD) decay in PWH receiving antiretroviral therapy (ART) are incompletely understood. We evaluated the effect of age, sex and markers of senescence on IPD decay, and examined individual decay slopes to assess whether there is heterogeneity in IPD changes. Methods Participants with long-term documented HIV suppression continuously followed…